Dianthus Therapeutics 320% Year: What Investors Should Know as Stakes Shift
Dianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Assess historical performance and potential in retirement for SP500 and Total Market funds, focusing on consistency and drawdown behavior.
28,444 articlesDianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Bitcoin traders are eyeing three main forces this week: fresh inflation readings, geopolitics, and evolving crypto po...
Snowflake delivered a monster quarter, beating expectations and setting the stage for a new era in software pricing d...
Bitcoin holds near $62,500 after a 15% weekly drop as traders await a regulatory milestone. Gemini AI warns the move ...
Kalshi and Polymarket have launched a coordinated policy crackdown on paid influencers promoting election fraud claim...
A luxury of near-new mileage becomes a liability if a dealer claims a major repair. This article breaks down what hap...
In Q1 2026, Duquesne Family Office quietly expanded its South American equity bets, signaling a macro-led stance that...
New BEA data shows inflation pressing higher again, complicating the Fed's policy path. Investors weigh rate bets as ...
Super Micro Computer and Dell Technologies rebounded after a sharp Monday drop tied to a Taiwan probe, with AI server...
A tight cluster of globally listed equities with durable moats are leading the AI disruption, supported by Goldman Sa...
Oil prices jumped as Iran declared the Strait of Hormuz closed, raising the prospect of prolonged supply disruption. ...
Intel has been sliding over the last month. One analyst argues the company could double its value as its foundry busi...